n-3 PUFA Esterified to Glycerol or as Ethyl Esters Reduce Non-Fasting Plasma Triacylglycerol in Subjects with Hypertriglyceridemia: A Randomized Trial

n-3 Fatty acids affect haemostasis but do not increase the risk of bleeding: clinical observations and mechanistic insights

(2014) John K. Wachira et al.   BRITISH JOURNAL OF NUTRITION

Low Nonfasting Triglycerides and Reduced All-Cause Mortality: A Mendelian Randomization Study

(2014) M. Thomsen et al.   CLINICAL CHEMISTRY

A randomized clinical trial to determine the efficacy of manufacturers’ recommended doses of omega-3 fatty acids from different sources in facilitating cardiovascular disease risk reduction

(2014) Maggie Laidlaw et al.   Lipids in Health and Disease

Associations between Omega-3 Index increase and triacylglyceride decrease in subjects with hypertriglyceridemia in response to six month of EPA and DHA supplementation

(2014) Jan Philipp Schuchardt et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Polyunsaturated omega-3 fatty acids reduce lipoprotein-associated phospholipase A2 in patients with stable angina

(2013) Grzegorz Gajos et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Bioavailability of long-chain omega-3 fatty acids

(2013) Jan Philipp Schuchardt et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events

(2012) Evangelos C. Rizos et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Moderate doses of EPA and DHA from re-esterified triacylglycerols but not from ethyl-esters lower fasting serum triacylglycerols in statin-treated dyslipidemic subjects: Results from a six month randomized controlled trial

(2011) J.P. Schuchardt et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women

(2010) Marie Therese Cooney et al.   AMERICAN HEART JOURNAL

Omega-3 fatty acid supplementation improves vascular function and reduces inflammation in obese adolescents

(2010) Frida Dangardt et al.   ATHEROSCLEROSIS

Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters

(2010) J Neubronner et al.   EUROPEAN JOURNAL OF CLINICAL NUTRITION

Omega-3 fatty acids and lipoprotein associated phospholipase A2 in healthy older adult males and females

(2010) T. L. Nelson et al.   EUROPEAN JOURNAL OF NUTRITION

Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

(2010)   LANCET

Bioavailability of marine n-3 fatty acid formulations

(2010) J. Dyerberg et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

The effect of marine n-3 fatty acids in different doses on plasma concentrations of Lp-PLA2 in healthy adults

(2008) Maria Weinkouff Pedersen et al.   EUROPEAN JOURNAL OF NUTRITION